IDYA
Price
$22.29
Change
+$0.28 (+1.27%)
Updated
Jun 26 closing price
Capitalization
1.95B
46 days until earnings call
KOD
Price
$3.78
Change
+$0.09 (+2.44%)
Updated
Jun 26 closing price
Capitalization
199.45M
52 days until earnings call
Interact to see
Advertisement

IDYA vs KOD

Header iconIDYA vs KOD Comparison
Open Charts IDYA vs KODBanner chart's image
IDEAYA Biosciences
Price$22.29
Change+$0.28 (+1.27%)
Volume$1.17M
Capitalization1.95B
Kodiak Sciences
Price$3.78
Change+$0.09 (+2.44%)
Volume$558.05K
Capitalization199.45M
IDYA vs KOD Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. KOD commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and KOD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (IDYA: $22.29 vs. KOD: $3.78)
Brand notoriety: IDYA and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 93% vs. KOD: 144%
Market capitalization -- IDYA: $1.95B vs. KOD: $199.45M
IDYA [@Biotechnology] is valued at $1.95B. KOD’s [@Biotechnology] market capitalization is $199.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileKOD’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • KOD’s FA Score: 1 green, 4 red.
According to our system of comparison, both IDYA and KOD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while KOD’s TA Score has 2 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • KOD’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than KOD.

Price Growth

IDYA (@Biotechnology) experienced а +1.97% price change this week, while KOD (@Biotechnology) price change was +7.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.61%. For the same industry, the average monthly price growth was +38.86%, and the average quarterly price growth was +17.21%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

KOD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+9.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.95B) has a higher market cap than KOD($199M). IDYA YTD gains are higher at: -13.268 vs. KOD (-62.010). KOD has higher annual earnings (EBITDA): -162.44M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. KOD (139M). IDYA has less debt than KOD: IDYA (26M) vs KOD (67.6M). IDYA has higher revenues than KOD: IDYA (7M) vs KOD (0).
IDYAKODIDYA / KOD
Capitalization1.95B199M981%
EBITDA-356.46M-162.44M219%
Gain YTD-13.268-62.01021%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash693M139M499%
Total Debt26M67.6M38%
FUNDAMENTALS RATINGS
IDYA vs KOD: Fundamental Ratings
IDYA
KOD
OUTLOOK RATING
1..100
7569
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
4852
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for IDYA (63) in the null industry. This means that KOD’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (69) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KOD’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as KOD (98) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KOD’s over the last 12 months.

IDYA's Price Growth Rating (48) in the null industry is in the same range as KOD (52) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KOD’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAKOD
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGMAX25.210.27
+1.08%
Janus Henderson Triton A
RCEYX58.30N/A
N/A
Victory RS Large Cap Alpha Y
FGRSX42.60N/A
N/A
Federated Hermes Intl Leaders R6
FSYKX10.03N/A
N/A
Fidelity Advisor Sustainable EM Eq C
VSFSX23.31N/A
N/A
Federated Hermes Clover Small Value R6

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.27%
IMNM - IDYA
60%
Loosely correlated
+1.27%
CGON - IDYA
60%
Loosely correlated
+0.04%
XENE - IDYA
56%
Loosely correlated
+1.39%
CRNX - IDYA
56%
Loosely correlated
-1.38%
COGT - IDYA
55%
Loosely correlated
+3.68%
More

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+2.44%
XNCR - KOD
54%
Loosely correlated
-1.87%
NRIX - KOD
48%
Loosely correlated
+1.89%
COGT - KOD
48%
Loosely correlated
+3.68%
BEAM - KOD
48%
Loosely correlated
+2.27%
IDYA - KOD
46%
Loosely correlated
+1.27%
More